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Background
Tourett's disorder is generally treated with antipsychotic
medication. Pure antidopaminergic activity is considered
the way antipsychotics act in these patients. Amisulpride
is the purest antidopaminergic atypical antipsychotic, and
thus could serve as an ideal choice for the treatment of
Tourett's disorder
Material and Methods
We report the case of a 40 years old married female suffer-
ing from Tourette's disorder.
Results
At the age of 5, the patient manifested involuntary head
movements, at the age of 8 involuntary leg movements
and by the age of 12–13 years vocal tics appeared. During
the previous 10 years the patient received mirtazapine,
buspirone, valproic and sulpride. Only sulpride had a
weak effect. The patient was assessed with the Yale Global
Tics Severity Scale. Her baseline motor score was 16, her
phonic score 18 and her impairment score 30. She was put
on amisulpride 100 mg per day. Three weeks later her
scores dropped to 9, 10 and 20 respectively. Amisulpride
was raised to 200 mg daily and after another three weeks
her scores were 5, 6 and 10 respectively. A further titration
to 400 mg/day was made but without further improve-
ment. The patient decreased the dose to 100 mg/day with-
out any deterioration in her condition. For the next three
months the patient continued receiving treatment and her
condition was stable. Then she decided to discontinue
because of amenorhea and within 20 days the symptoms
reappeared. Her scores climbed to 10, 11 and 30. The
patient decided to restart amisulpride treatment and
simultaneously started visiting a gynecologist for the treat-
ment of amenorhea.
Discussion
To our knowledge this is the first report concerning the
use of amisulpride in Tourette's disorder.
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